Intensive Arterial Pressure Control in Acute Coronary Syndrome

• Status: Recruiting
• Trial end date: 2030-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The intensive arterial pressure control in acute coronary syndrome (ACS) during the first 24 hours can improve the prognosis in the short and long term.

We compare two treatment strategies (standard and intensive treatment) to assess their efficacy and safety in the treatment of acute coronary syndrome.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Monastir
• Collaborator: Emergency NGO Onlus
• Treatments: Antihypertensive Agents; Isosorbide; Isosorbide Dinitrate; Isosorbide-5-mononitrate; Labetalol; Nicardipine

Criteria

Inclusion Criteria:

• Acute Coronary Syndrome

Exclusion Criteria:

• SBP under 100 mmHg or hemodynamic instability

• complicated ACS (arrythmias, atrio-ventricular block, shock, tamponade...) or ST elevation myocardial infarction (STEMI)

• contre indications of beta blockers (asthma, chronic obstructive pulmonary disease (COPD), glaucoma, prostatic disorders...)